KYLIE BONNEAU: Open Payments
NPI 1831933076 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 38 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $251 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $394 |
| Exact Sciences Corporation | 3 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76 |
| Abbott Laboratories | 1 | $52 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Lilly USA, LLC | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $27 |
| Tris Pharma Inc | 1 | $25 |
Products named: Ozempic, Cologuard Collection Kit, JARDIANCE, Wegovy, AFINION 2, SHINGRIX, MOUNJARO, Kerendia.
Industry payments across TX — which companies pay providers there.
